Brand-Schieber E - Search Results

1

Connexin43, the major gap junction protein of astrocytes, is down-regulated in inflamed white matter in an animal model of multiple sclerosis.

Brand-Schieber E, Werner P, Iacobas DA, Iacobas S, Beelitz M, Lowery SL, Spray DC, Scemes E. Brand-Schieber E, et al. J Neurosci Res. 2005 Jun 15;80(6):798-808. doi: 10.1002/jnr.20474. J Neurosci Res. 2005. PMID: 15898103 Free PMC article.

2

(+/-)-Alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and kainate receptor subunit expression in mouse versus rat spinal cord white matter: similarities in astrocytes but differences in oligodendrocytes.

Brand-Schieber E, Werner P. Brand-Schieber E, et al. Neurosci Lett. 2003 Jul 17;345(2):126-30. doi: 10.1016/s0304-3940(03)00469-5. Neurosci Lett. 2003. PMID: 12821187

3

Select ionotropic glutamate AMPA/kainate receptors are expressed at the astrocyte-vessel interface.

Brand-Schieber E, Lowery SL, Werner P. Brand-Schieber E, et al. Brain Res. 2004 May 8;1007(1-2):178-82. doi: 10.1016/j.brainres.2003.12.051. Brain Res. 2004. PMID: 15064149

4

Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis.

Brand-Schieber E, Werner P. Brand-Schieber E, et al. Exp Neurol. 2004 Sep;189(1):5-9. doi: 10.1016/j.expneurol.2004.05.023. Exp Neurol. 2004. PMID: 15296830

5

AMPA/kainate receptors in mouse spinal cord cell-specific display of receptor subunits by oligodendrocytes and astrocytes and at the nodes of Ranvier.

Brand-Schieber E, Werner P. Brand-Schieber E, et al. Glia. 2003 Apr 1;42(1):12-24. doi: 10.1002/glia.10136. Glia. 2003. PMID: 12594733

6

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease.

Farlow M, Veloso F, Moline M, Yardley J, Brand-Schieber E, Bibbiani F, Zou H, Hsu T, Satlin A. Farlow M, et al. BMC Neurol. 2011 May 25;11:57. doi: 10.1186/1471-2377-11-57. BMC Neurol. 2011. PMID: 21612646 Free PMC article. Clinical Trial.

7

DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment.

Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM. Lipton RB, et al. Among authors: brand schieber e. CNS Drugs. 2019 Apr;33(4):375-382. doi: 10.1007/s40263-019-00614-6. CNS Drugs. 2019. PMID: 30877622 Free PMC article. Clinical Trial.

8

DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.

Lipton RB, Munjal S, Brand-Schieber E, Rapoport AM. Lipton RB, et al. Among authors: brand schieber e. Headache. 2018 May;58(5):676-687. doi: 10.1111/head.13309. Headache. 2018. PMID: 29878341 Clinical Trial.

9

Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.

Lipton RB, Munjal S, Brand-Schieber E, Tepper SJ, Dodick DW. Lipton RB, et al. Among authors: brand schieber e. Headache. 2020 Jan;60(1):58-70. doi: 10.1111/head.13663. Epub 2019 Oct 24. Headache. 2020. PMID: 31647577 Free PMC article. Clinical Trial.

10

Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.

Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A. Farlow MR, et al. Clin Ther. 2010 Jul;32(7):1234-51. doi: 10.1016/j.clinthera.2010.06.019. Clin Ther. 2010. PMID: 20678673 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters